Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Department of Pediatric Endocrinology and Diabetes, Marmara University School of Medicine, Istanbul, Turkey.
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3049-3067. doi: 10.1210/jc.2019-00248.
Primary ovarian insufficiency (POI) encompasses a spectrum of premature menopause, including both primary and secondary amenorrhea. For 75% to 90% of individuals with hypergonadotropic hypogonadism presenting as POI, the molecular etiology is unknown. Common etiologies include chromosomal abnormalities, environmental factors, and congenital disorders affecting ovarian development and function, as well as syndromic and nonsyndromic single gene disorders suggesting POI represents a complex trait.
To characterize the contribution of known disease genes to POI and identify molecular etiologies and biological underpinnings of POI.
DESIGN, SETTING, AND PARTICIPANTS: We applied exome sequencing (ES) and family-based genomics to 42 affected female individuals from 36 unrelated Turkish families, including 31 with reported parental consanguinity.
This analysis identified likely damaging, potentially contributing variants and molecular diagnoses in 16 families (44%), including 11 families with likely damaging variants in known genes and five families with predicted deleterious variants in disease genes (IGSF10, MND1, MRPS22, and SOHLH1) not previously associated with POI. Of the 16 families, 2 (13%) had evidence for potentially pathogenic variants at more than one locus. Absence of heterozygosity consistent with identity-by-descent mediated recessive disease burden contributes to molecular diagnosis in 15 of 16 (94%) families. GeneMatcher allowed identification of additional families from diverse genetic backgrounds.
ES analysis of a POI cohort further characterized locus heterogeneity, reaffirmed the association of genes integral to meiotic recombination, demonstrated the likely contribution of genes involved in hypothalamic development, and documented multilocus pathogenic variation suggesting the potential for oligogenic inheritance contributing to the development of POI.
原发性卵巢功能不全(POI)涵盖了一系列过早绝经,包括原发性和继发性闭经。对于 75%至 90%的表现为 POI 的高促性腺激素性性腺功能减退症个体,其分子病因尚不清楚。常见病因包括染色体异常、环境因素以及影响卵巢发育和功能的先天性疾病,以及综合征和非综合征单基因疾病,这表明 POI 代表一种复杂的特征。
描述已知疾病基因对 POI 的贡献,并确定 POI 的分子病因和生物学基础。
设计、设置和参与者:我们应用外显子组测序(ES)和基于家系的基因组学方法对 36 个无关土耳其家族的 42 名受影响女性个体进行分析,其中 31 名个体报告有父母近亲结婚史。
这项分析在 16 个家族(44%)中发现了可能具有破坏性、可能具有致病性的变异体和分子诊断,包括 11 个家族中已知基因的可能具有破坏性变异体和 5 个家族中预测的疾病基因(IGSF10、MND1、MRPS22 和 SOHLH1)中的有害变异体,这些基因以前与 POI 无关。在 16 个家族中,有 2 个(13%)家族在一个以上的基因座有证据表明存在潜在的致病性变异体。16 个家族中有 15 个(94%)家族存在一致的杂合缺失,提示存在隐性疾病负担,这有助于分子诊断。GeneMatcher 允许从不同遗传背景中识别更多的家族。
对 POI 队列进行 ES 分析进一步描述了基因座异质性,再次证实了与减数分裂重组密切相关的基因的关联,证明了参与下丘脑发育的基因的可能贡献,并记录了多基因致病性变异,表明多基因遗传可能有助于 POI 的发展。